Australia Blood Transfusion Diagnostics Market Size & Outlook
Australia blood transfusion diagnostics market, 2016-2027 (US$M)
Related Markets
Australia blood transfusion diagnostics market highlights
- The Australia blood transfusion diagnostics market generated a revenue of USD 68.9 million in 2020 and is expected to reach USD 121.6 million by 2027.
- The Australia market is expected to grow at a CAGR of 8.4% from 2021 to 2027.
- In terms of segment, reagents & kits was the largest revenue generating product in 2020.
- Reagents & Kits is the most lucrative product segment registering the fastest growth during the forecast period.
Blood transfusion diagnostics market data book summary
| Market revenue in 2020 | USD 68.9 million |
| Market revenue in 2027 | USD 121.6 million |
| Growth rate | 8.4% (CAGR from 2020 to 2027) |
| Largest segment | Reagents & kits |
| Fastest growing segment | Reagents & Kits |
| Historical data | 2016 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Reagents & Kits, Instruments |
| Key market players worldwide | Grifols SA Ordinary Shares - Class A, Bio-Rad Laboratories Inc, Roche Holding AG ADR, Quotient Sciences, Abbott Laboratories, BioMerieux SA, Siemens Healthineers AG ADR, MedGenome, Beckman Coulter |
Other key industry trends
- In terms of revenue, Australia accounted for 1.9% of the global blood transfusion diagnostics market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
- In Asia Pacific, Japan blood transfusion diagnostics market is projected to lead the regional market in terms of revenue in 2027.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 295.1 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood Transfusion Diagnostics Market Scope
Blood Transfusion Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia blood transfusion diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood transfusion diagnostics market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 66.62% in 2020. Horizon Databook has segmented the Australia blood transfusion diagnostics market based on reagents & kits, instruments covering the revenue growth of each sub-segment from 2016 to 2027.
According to Australian Red Cross data, one in three Australians is expected to need blood and blood components in their lifetime. It is also estimated that over 29,000 donations are needed every week in the country. However, only 3% of Australians donate blood each year.
Hence, there is high need for blood donations in the country; one donation can save up to three lives, as per Australian Red Cross statistics. The country is engaged in organizing various awareness programs to encourage more people to donate blood.
For instance, in June 2019, Australian Red Cross Blood Service organized its first event, 24-hour donate-a-thon on World Blood Donor Day, partnering with Banter and Hausmann. This was aimed at encouraging more Australian people to donate blood.
Reasons to subscribe to Australia blood transfusion diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia blood transfusion diagnostics market databook
-
Our clientele includes a mix of blood transfusion diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia blood transfusion diagnostics market, including forecasts for subscribers. This country databook contains high-level insights into Australia blood transfusion diagnostics market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
Australia blood transfusion diagnostics market size, by product, 2016-2027 (US$M)
Australia Blood Transfusion Diagnostics Market Share, 2020 & 2027 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
